2026/06/23
Drug Regulatory News | China National Medical Products Administration's Drug Evaluation Center Issues the "Annual Report on the Progress of New Drug Clinical Trials in China (2025)"
To showcase the current status of clinical trials for new drug registration in China, further enhance the transparency of clinical trials, and provide scientific references for new drug research and evaluation approval, the Drug Evaluation Center of the National Medical Products Administration uses clinical trial data from the Drug Clinical Trial Registration and Information Disclosure Platform...
More
